2.20

0.00% 0.00

After Hours: 2.20

Xbiotech Inc (XBIT)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Xbiotech Inc stock is traded at $2.20, with a volume of 118.61K. It is up +0.00% in the last 24 hours and down -1.79% over the past month. XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Previous Close:

$2.20

Open:

$2.2

24h Volume:

118.61K

Relative Volume:

2.98

Market Cap:

$67.07M

Revenue:

$300.00K

Net Income/Loss:

$-40.16M

P/E Ratio:

-1.67

EPS:

-1.3174

Net Cash Flow:

$-42.36M

1W Performance:

-3.08%

1M Performance:

-1.79%

6M Performance:

-6.38%

1Y Performance:

-26.17%

1-Day Range:

$2.19

$2.25

1-Week Range:

$2.19

$2.31

52-Week Range:

$2.09

$3.44

Xbiotech Inc Stock (XBIT) Company Profile

Name

Xbiotech Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

512-386-2900

Address

5217 WINNEBAGO LANE, AUSTIN, TX

Employee

Twitter

@xbiotech_usa

Next Earnings Date

2026-08-12

Latest SEC Filings

XBIT's Discussions on Twitter

Compare XBIT vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XBIT Xbiotech Inc	2.20	70.43M	300.00K	-40.16M	-42.36M	-1.3174
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-14-19	Initiated	Piper Jaffray	Overweight
Apr-21-17	Downgrade	Noble Financial	Buy → Hold
Jun-28-16	Reiterated	Noble Financial	Buy

Xbiotech Inc Stock (XBIT) Latest News

Sep 03, 2026

XBiotech (NASDAQ:XBIT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat

Sep 03, 2026

Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Supply Zone - vinanet.vn

Sep 01, 2026

Aug 26, 2026

XBiotech (NASDAQ:XBIT) Share Price Passes Above 50 Day Moving AverageHere's What Happened - MarketBeat

Aug 26, 2026

Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - vinanet.vn

Aug 24, 2026

Aug 13, 2026

XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS - MarketBeat

Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - AOL.com

Aug 13, 2026

XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026 - Stock Titan

Aug 13, 2026

XBiotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceIV Spike - vinanet.vn

Aug 11, 2026

Aug 10, 2026